Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Aimia | 157 | 2022 | |||||||||
ΠΠ΅Π»ΠΎΠ½ | 145 | 2024q2 | |||||||||
Houston American Energy | 13 | 2021 | |||||||||
Franco-Nevada | 34,287 | 2024q1 | |||||||||
Keyence | 130,656 | 2024q1 | |||||||||
Atea Pharmaceuticals | 292 | 2023q3 | |||||||||
Ebang International Holdi... | 49 | 2023q2 | |||||||||
Krystal Biotech | 4,683 | 2023q2 | |||||||||
Black Stone Minerals LP | 3,295 | 2024q2 | |||||||||
Hyliion Holdings | 445 | 2024q2 | |||||||||
Cassava Sciences | 1,231 | 2021 | |||||||||
Guardion Health Sciences | 491 | 2021 | |||||||||
RLX Technology | 2,554 | 2022 | |||||||||
Vuzix | 57 | 2023q3 | |||||||||
Simulations Plus | 613 | 2023q3 | |||||||||
Farmmi | 6 | 2022 | |||||||||
India Globalization Capit... | 25 | 2022q3 | |||||||||
ΠΠ Π‘ΠΠΠΠ Π Π£Π | 12 | 2023 | |||||||||
Prelude Therapeutics | 294 | 2023q2 | |||||||||
Qudian | 465 | 2024q1 |